Tvardi Therapeutics, Inc. (TVRD) Volatility Skew
Implied volatility skew shows how IV varies across strike prices for a given expiration. Steeper skews indicate higher demand for downside protection relative to upside speculation.
Tvardi Therapeutics, Inc. (TVRD) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $37.1M, listed on NASDAQ, employing roughly 17 people, carrying a beta of 0.30 to the broader market. Tvardi Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel, oral small molecule therapies targeting STAT3 to treat fibrosis-driven diseases with significant unmet need. Led by Imran Alibhai, public since 2025-04-16.
Snapshot as of May 15, 2026.
- Spot Price
- $4.02
- ATM IV
- 21.6%
- IV Rank
- 0.9%
- IV Percentile
- 5.5%
- Term Structure Slope
- -0.027
As of May 15, 2026, Tvardi Therapeutics, Inc. (TVRD) at-the-money implied volatility is 21.6%. IV rank is 0.9% (where 0% is the 52-week low and 100% is the 52-week high). IV percentile is 5.5%. High IV rank typically favors premium-selling strategies; low IV rank favors premium-buying.
TVRD Strategy Selection at Current Volatility Levels
For Tvardi Therapeutics, Inc. options at 21.6% ATM IV, low IV rank (0.9%) favors premium-buying or long-vol structures: long calls or puts, debit spreads, calendar spreads, long straddles. The risk: low-rank regimes can persist for months while time decay eats premium-buyers alive. Pair the vol-rank read with the dealer-gamma view and the upcoming-events calendar to confirm the strategy fits both the structural regime and the path-dependent risk. The variance risk premium - the persistent gap between implied and subsequently realized vol - is positive in equity markets on average; high IV rank typically reflects a stretch where the premium is wider than usual.
Learn how volatility skew is reported and how to read the data →
Frequently asked TVRD volatility skew questions
- What is the current TVRD ATM implied volatility?
- As of May 15, 2026, Tvardi Therapeutics, Inc. (TVRD) at-the-money implied volatility is 21.6%. IV rank is 0.9% on a 0-100% scale anchored to the 1-year IV range. ATM IV is the volatility input that makes a Black-Scholes-equivalent model reproduce the listed at-the-money option prices.
- Is TVRD IV high or low historically?
- IV is subdued relative to its 1-year history, conditions that typically favor premium-buying strategies (long calls, long puts, debit spreads, calendar spreads).
- What does TVRD volatility skew tell options traders?
- Volatility skew is the pattern by which IV varies across strikes for a given expiration. Skew matters for risk-defined strategy selection: when downside puts are rich, put-credit spreads capture more premium; when upside calls are rich, call-credit spreads or covered-call writes harvest more.